Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trial

Laura Danielle Wagner, Michaela Obersriebnig, Vera Kadlecek, Romana Hochreiter, Santhosh Kumar Ghadge, Julian Larcher‐Senn, Lisa Hegele, Jason D. Maguire, Ulla Derhaschnig, Juan Carlos Jaramillo, Susanne Eder-Lingelbach, Nicole Bézay